Iodinated contrast medium: Is there a re(n)al problem? A clinical
As we were taught, for decades, that iodinated contrast-induced acute kidney injury should be dreaded, considerable efforts were made to find out effective measures in mitigating the renal risk of iodinated contrast media. Imaging procedures were frequently either downgraded (unenhanced imaging) or deferred as clinicians felt that the renal risk pertaining to contrast administration outweighed the benefits of an enhanced imaging. However, could we have missed the point? Among the abundant literature about iodinated contrast-associated acute kidney injury, recent meaningful advances may help sort out facts from false beliefs. Hence, there is increasing evidence that the nephrotoxicity directly attributable to modern iodinated CM has been exaggerated. Failure to demonstrate a clear benefit from most of the tested prophylactic measures might be an indirect consequence. However, the toxic potential of iodinated contrast media is well established experimentally and should not be overlooked completely when making clinical decisions. We herein review these advances in disease and pathophysiologic understanding and the associated clinical crossroads through a typical case vignette in the critical care setting.
Contrast CT - Wikipedia
Iodinated Contrast Media Shortage: Practical Solutions and
Stratified assessment and warning regimen for prevention of acute
Risk of Intravenous Contrast Material–mediated Acute Kidney Injury
Waiting times between examinations with intravascularly
Contrast Media - FV Hospital
Forest plot demonstrating change in creatinine levels
Frequency of Acute Kidney Injury Following Intravenous Contrast
Contrast-Induced Acute Kidney Injury - ScienceDirect
Use of Nanoparticle Contrast Agents for Cell Tracking with
Oral N‑acetylcysteine for prophylaxis of contrast‑induced
Gadolinium on CT - Questions and Answers in MRI
CT and MRI Contrast and Kidney Function
